科士达(002518) - 2020 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was CNY 693,307,781.37, an increase of 7.81% year-on-year [7]. - Net profit attributable to shareholders was CNY 102,340,182.14, a decrease of 4.26% compared to the same period last year [7]. - Basic earnings per share were CNY 0.17, a decrease of 10.53% year-on-year [7]. - The weighted average return on net assets was 3.81%, down 0.50% from the previous year [7]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 95,418,429.23, a decrease of 15.87% year-on-year [7]. - Total operating revenue for Q3 2020 was CNY 693,307,781.37, an increase from CNY 643,091,376.04 in the same period last year, representing a growth of approximately 7.5% [89]. - The total profit for the current period was ¥119,428,215.96, slightly down from ¥124,080,981.77, a decrease of 3.67% [95]. - Comprehensive income attributable to the parent company was ¥102,316,595.13, a decrease from ¥106,924,618.29, reflecting a decline of 4.99% [99]. - The company reported a total comprehensive income of ¥234,292,631.92, compared to ¥230,754,104.47 in the previous period, indicating a growth of 1.5% [114]. Cash Flow - Net cash flow from operating activities was CNY 153,529,814.07, down 50.10% from the previous year [7]. - Cash and cash equivalents decreased by 31.08% to ¥493.83 million due to increased payments for goods [20]. - The net cash flow from operating activities decreased by 90.05% to ¥62.35 million, driven by reduced sales collections [23]. - Cash inflow from operating activities totaled ¥1.80 billion, down from ¥1.99 billion year-over-year, reflecting a decrease of about 9.7% [123]. - The net cash flow from operating activities was ¥62.35 million, a decline from ¥626.34 million in the previous period [123]. - The ending cash and cash equivalents balance was ¥466.91 million, down from ¥640.82 million in the previous period [125]. - The company reported a decrease in cash received from sales of goods and services to ¥1.52 billion from ¥1.62 billion year-over-year [129]. - The company's total cash outflow from operating activities was ¥1.82 billion, compared to ¥1.40 billion in the previous period, indicating an increase of approximately 30.5% [129]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,989,585,364.19, a decrease of 1.66% compared to the end of the previous year [7]. - The total liabilities decreased to CNY 1,270,817,901.90 from CNY 1,486,341,309.42, reflecting a reduction of about 14.5% [89]. - The total assets as of September 30, 2020, amounted to CNY 3,756,172,089.56, a decrease from CNY 3,864,357,726.78 at the end of 2019 [86]. - The total liabilities increased from 1,431,683,742.91 to 1,432,334,302.36, showing a slight rise in total liabilities [142]. - The total current assets were reported at 2,887,826,031.94, a decrease from 2,889,965,423.76, reflecting a decline of approximately 0.07% [136]. - The company's retained earnings increased from 1,349,842,711.05 to 1,351,205,180.89, showing a growth of approximately 0.1% [142]. Shareholder Information - The total number of shareholders at the end of the reporting period was 18,947 [12]. - The largest shareholder, Xinjiang KSTAR Equity Investment Partnership, held 59.74% of the shares [12]. - The company has repurchased a total of 220,300 shares, accounting for 0.0378% of the total share capital, with a total transaction amount of approximately ¥1,998,943.71 [26]. Legal Matters - The company is currently involved in multiple lawsuits with a total amount in dispute of ¥11.93 million, with some cases already won [24]. - The company has won lawsuits related to product sales contracts, with amounts including ¥80.59 million and ¥351.1 million, and has applied for enforcement in these cases [26]. - The company has partially recovered funds from various lawsuits, indicating ongoing legal proceedings and settlements [26]. Government Subsidies and Other Income - The company received government subsidies amounting to CNY 15,910,043.44 during the reporting period [7]. - Other income decreased by 31.65% to ¥19.74 million, mainly due to reduced government subsidies received [20]. - The company reported a significant increase in investment income by 4143.52% to ¥16.77 million, attributed to increased purchases of financial products [20]. Financial Management - The company reported a total of 153,589,000 CNY in entrusted financial management, with an outstanding balance of 50,350,000 CNY [39]. - The company has no overdue amounts in its entrusted financial management activities [39]. - The expected annualized return rates for various entrusted financial products range from 3.65% to 4.20% [40]. - The actual profit from entrusted financial management during the reporting period was 101.1 million CNY, with 104.47 million CNY already recovered [40]. - The company has maintained compliance with legal procedures in its financial management activities [40]. Research and Development - Research and development expenses increased to ¥36,310,920.10, reflecting a growth of 2.34% from ¥35,476,401.13 [95]. - Research and development expenses increased to ¥102,846,607.66, up from ¥89,968,785.61, representing a growth of 14.5% [107].